NICE Ltd. (NCSYF) VP files Form 3 on stock option holdings

Rhea-AI Filing Summary

NICE Ltd. executive Udi Yehuda Dayan, VP of Corporate Finance, filed an initial insider report listing existing stock option holdings in the company’s Ordinary Shares. The filing shows options over 750 Ordinary Shares at an exercise price of 0.3060 expiring on March 14, 2028, and 3,000 Ordinary Shares at an exercise price of 0.3134 expiring on December 23, 2031, among other grants. Footnotes explain that some options are already vested and exercisable, while others will vest in scheduled installments through 2030. No new purchases or sales are reported; this Form 3 simply establishes Dayan’s existing option positions.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Dayan Udi Yehuda

Role VP, Corporate Finance

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Options — 750 shares (Direct)

Footnotes (1)

1. The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 162 Ordinary Shares and will vest with respect to the remaining shares on November 1, 2026. The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in two substantially equal installments on November 1, 2026 and November 1, 2027. The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on November 1, 2026, November 1, 2027 and November 1, 2028. The stock option will vest in substantially equal installments on January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dayan Udi Yehuda

(Last) (First) (Middle)

221 RIVER STREET

(Street)

HOBOKEN 07030

(City) (State) (Zip)

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Corporate Finance

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	(1)	03/14/2028	Ordinary Shares	750	$0.306	D
Options	(2)	11/01/2028	Ordinary Shares	325	$0.2833	D
Options	(3)	11/01/2029	Ordinary Shares	825	$0.2531	D
Options	(4)	11/01/2030	Ordinary Shares	1,100	$0.2687	D
Options	(5)	12/23/2031	Ordinary Shares	3,000	$0.3134	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 162 Ordinary Shares and will vest with respect to the remaining shares on November 1, 2026.

3. The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in two substantially equal installments on November 1, 2026 and November 1, 2027.

4. The stock option is vested and exercisable with respect to 275 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on November 1, 2026, November 1, 2027 and November 1, 2028.

5. The stock option will vest in substantially equal installments on January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Udi Dayan Yehuda	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NICE (NCSYF) Form 3 filing by Udi Yehuda Dayan show?

The Form 3 shows VP of Corporate Finance Udi Yehuda Dayan’s existing stock option holdings in NICE Ltd. It lists multiple option grants over Ordinary Shares, including exercise prices, expiration dates, and vesting schedules, without reporting any new purchases or sales.

Did Udi Yehuda Dayan buy or sell NICE (NCSYF) shares in this Form 3?

No, the Form 3 does not report any purchases or sales of NICE shares. It only discloses Dayan’s current stock option positions, detailing the number of underlying Ordinary Shares, exercise prices, expiration dates, and how and when the options vest over time.

What stock option grants are disclosed for NICE (NCSYF) VP Udi Yehuda Dayan?

The filing lists several option grants, including options over 750 Ordinary Shares at an exercise price of 0.3060 expiring March 14, 2028, and 3,000 Ordinary Shares at 0.3134 expiring December 23, 2031. Additional grants cover smaller amounts with varying prices and expiration dates.

How are the NICE (NCSYF) options held by Udi Yehuda Dayan vesting?

Footnotes explain that some options are already fully vested and exercisable, while others vest in installments. Certain grants vest on November 1 in 2026, 2027 and 2028, and another grant vests in substantially equal installments on January 6, 2027, 2028, 2029 and 2030.

What is the significance of the expiration dates in the NICE (NCSYF) Form 3?

Expiration dates indicate how long Dayan can exercise each option grant. The disclosed options expire between March 14, 2028 and December 23, 2031, providing several years during which he may choose to convert vested options into Ordinary Shares if conditions are favorable.

Does the NICE (NCSYF) Form 3 indicate direct or indirect ownership of the options?

The Form 3 classifies all reported options as directly owned by Udi Yehuda Dayan. The records list ownership type as direct, with no footnotes indicating that the options are held through trusts, family entities, or other indirect ownership structures.